Clinical trial
Favourable and Unfavourable Health Effects of Risk-Reducing Salpingo-Oophorectomy in Women With a High Genetic Risk of Ovarian Cancer
NCT03835793 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Favourable and Unfavourable Health Effects of Risk-Reducing Salpingo-Oophorectomy in Women With a High Genetic Risk of Ovarian Cancer
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 11, 2019
- Completion date
- January 1, 2022
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bone mineral density, brca1 mutation, brca2 mutation, cardiovascular diseases, cognitive decline, menopause surgical, quality of life, surgical menopause